Clinical Trials Sponsored by Wingate Institute

Total 74599 results

Wingate Institute

Completed

Range of Motion, Humeral Retroversion and Rotator Cuff (RC) Muscle Strength of the Shoulder in Overhead Athletes

Shoulder Pain

Israel
Wingate Institute

Completed

The Effect of Infrapatellar Strap Treatment on Pain Extent and Athletic Measures in Young Athletes

Patellar Tendonitis | Jumper's Knee | Patellar Tendinopathy

Israel
Wingate Institute

Completed

The Effects of Vibration Therapy as a Recovery Tool After Intense Exercise

Muscle Performance | Recovery Method | Vibration Therapy

Israel
Wingate Institute

Completed

Vibration Training and Muscle Strength Development

Muscle Strength | Disabilities of the Arm, Shoulder and Hand

Israel
Wingate Institute

Completed

Health Promotion Intervention Program at the Workplace

Conditions Influencing Health Status

Israel
Wingate Institute

Completed

Connection Between Sleep and Athletic Performance

Athletic Performance | Quality Sleep Time

Israel
Wingate Institute of Neurogastroenterology

Unknown

Caecal pH as a Biomarker for Irritable Bowel Syndrome

Irritable Bowel Syndrome

United Kingdom
Wingate Institute of Neurogastroenterology

Completed

Effect of Transcutaneous Vagal Nerve Stimulation on Reducing Visually Induced Motion Sickness in Healthy Volunteers

Visually Induced Motion Sickness in Healthy Volunteers

United Kingdom
Loewenstein Hospital
Wingate Institute

Recruiting

The Effect of Pharmacological Treatment for ADHD on Physical Performance in Male Adolescents

ADHD

Israel
Wingate Institute of Neurogastroenterology

Unknown

The Effect of Transcutaneous Vagal Nerve Stimulation on Reducing Oesophageal Pain Hypersensitivity

Esophageal Diseases

United Kingdom
Wingate Institute
Tel Aviv University

Completed

Physical Fitness Effect on the Different Oxidative Stress Measurements

Oxidative Stress

Israel
Hillel Yaffe Medical Center
Wingate Institute

Unknown

The Effects of Newcomball Training on Physical Fitness and Mood State of Middle Age Women in Israel

Healthy

Israel
Hillel Yaffe Medical Center
Wingate Institute

Unknown

Genetic Polymorphism and Israeli Top-level Swimmers' Performance and Expertise

Genetic Polymorphism Connected to Top-level Swimmers

Israel
Hillel Yaffe Medical Center
Wingate Institute

Unknown

The Effectiveness of Attentional Strategies on Throwing Performance and Gaze Behavior of Self-paced Tasks Under Fatigue and Non-fatigue Conditions

Motor Learning
Hillel Yaffe Medical Center
Wingate Institute

Unknown

Genetic Polymorphism and Israeli Top-level Athletes

Top-level Athletes

Israel
University of Haifa
The Academic college Levinsky-Wingate at the Wingate Institute, Netanya,...

Recruiting

Growth Process and Development of the Musculoskeletal System in Young Gymnasts

Development, Adolescent

Israel
Loewenstein Hospital
Tel Aviv University; Wingate Institute

Recruiting

The Effects of a Single Dose of Methylphenidate on Motor Performance

ADHD

Israel
Maastricht University Medical Center
Wingate Institute of Neurogastroenterology

Recruiting

Neural Correlates of tVNS

fMRI | Transcutaneous Vagal Nerve Stimulation (tVNS) | Nucleus of the Solitary Tract (NTS)

Netherlands, United Kingdom
St George's, University of London
Wingate Institute of Neurogastroenterology

Recruiting

Gastro-intestinal Physiology After Anti-Reflux Procedures (GASP)

Gastroesophageal Reflux

United Kingdom
Hillel Yaffe Medical Center
Wingate College

Unknown

Effect of Proprioceptive Intervention Training on Power Capacity, Proprioceptive Ability and Technique of Young Swimmers

Injury Prevention

Israel
Kinnate Biopharma

Active, not recruiting

A Study to Evaluate KIN-3248 in Participants With Advanced Tumors Harboring FGFR2 and//or FGFR3 Gene Alterations

Intrahepatic Cholangiocarcinoma | Urothelial Carcinoma | Solid Tumor, Adult

United States, Korea, Republic of, Taiwan, China, Denmark, Spain
Changzheng-Cinkate

Terminated

An Open-Label, Study to Treat Patients With Renal Allograft and Polyoma BK Viruria

Viremia | Viruria

United States
Jules Bordet Institute
Innate Pharma

Withdrawn

Assessment of Metabolic & Path Response w/ RCT & ImT Before Surgery in Locally Advanced Esoph and Gastro-esoph Jction CA (ARTEMIS-Eso)

Adenocarcinoma of the Gastroesophageal Junction | Squamous Cell Carcinoma of the Esophagus | Adenocarcinoma of the Esophagus

Belgium
Institut Paoli-Calmettes
Innate Pharma

Recruiting

A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors (CHANCES)

Metastatic Cancer | Metastatic Lung Cancer | Metastatic Breast Cancer | Advanced Solid Tumor | Endometrial Cancer | Metastatic Gastric Cancer | Metastatic Pancreatic Cancer | Oesophageal Cancer | Metastatic Ovary Cancer

France
Institut Paoli-Calmettes
Innate Pharma

Unknown

Study of a Humanized Antibody Initiated 2 Months After an HLA Matched Allogenic Stem Cell Transplantation (PIRAT)

Hematologic Malignancies

France
Innate Pharma

Recruiting

Phase1/2 Study of IPH6501 in Patients With Relapsed /Refractory B-Cell Non-Hodgkin Lymphoma

Non Hodgkin Lymphoma

United States, Australia
Innate Pharma

Recruiting

IPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (MATISSE)

Non Small Cell Lung Cancer

France, United States, Greece, Hungary, Poland
Innate Pharma

Completed

Evaluation of Activity, Safety and Pharmacology of IPH2101 a Human Monoclonal Antibody in Patients With Multiple Myeloma (REMYKIR)

Multiple Myeloma

France
Innate Pharma

Terminated

Efficacy Study of Pre-operative IPH2201 in Patients With Squamous Cell Carcinoma of the Oral Cavity

Squamous Cell Carcinoma of the Oral Cavity

Germany, Spain
Innate Pharma

Completed

Safety and Tolerability of NNC0141-0000-0100 in Subjects With Rheumatoid Arthritis

Inflammation | Rheumatoid Arthritis

Germany
Innate Pharma

Completed

Safety and Efficacy of Lacutamab in Patients With Relapsed/Refractory Peripheral T-cell Lymphoma That Express KIR3DL2

Peripheral T Cell Lymphoma

Korea, Republic of, United States
Innate Pharma

Active, not recruiting

IPH4102 Alone or in Combination With Chemotherapy in Patients With Advanced T Cell Lymphoma (TELLOMAK)

Lymphoma, T-Cell | Lymphoma, T-Cell, Cutaneous | Mycosis Fungoides/Sezary Syndrome

United States, Spain, France, Italy, Belgium, Austria, Germany, Poland
Innate Pharma

Completed

Study of IPH4102 in Patients With Relapsed/Refractory Cutaneous T-cell Lymphomas (CTCL)

Cutaneous T-Cell Lymphoma

United States, France, Netherlands, United Kingdom
Innate Pharma

Terminated

Combination Study of IPH2201 (Monalizumab) With Ibrutinib in Relapsed, Refractory or Previously Untreated CLL

Chronic Lymphocytic Leukemia

United States
Innate Pharma

Completed

Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR) (EFFIKIR)

Acute Myeloid Leukemia

France
Innate Pharma

Completed

An Open-label, Dose-escalation Safety and Tolerability Trial Assessing Anti-KIR (1-7F9) in Subjects With Multiple Myeloma

Multiple Myeloma

United States
Innate Pharma

Completed

Study on the Anti-tumor Activity, Safety and Pharmacology of IPH2101 in Patients With Smoldering Multiple Myeloma (KIRMONO)

Smoldering Multiple Myeloma

United States
Innate Pharma

Completed

A Safety and Tolerability Extension Trial Assessing Repeated Dosing of Anti-KIR (1-7F9) Human Monoclonal Antibody in Patients With Acute Myeloid Leukaemia

Acute Myeloid Leukemia

France
Innate Pharma

Completed

Study on the Safety, Anti-tumor Activity and Pharmacology of IPH2101 Combined With Lenalidomide in Patients With Multiple Myeloma Experiencing a First or Second Relapse (KIRIMID)

Patients With Multiple Myeloma Experiencing a | First or Second Relapse

United States
Xinnate AB
Region Skane

Completed

Safety, Tolerability, and Pharmacokinetics of Ascending Topical Doses of TCP-25 Applied to Epidermal Suction Blister Wounds, Non-Healing Leg Ulcers and Patients With Dystrophic Epidermolysis Bullosa.

Blister | Epidermolysis Bullosa | Wound of Skin | Varicose Ulcer of Lower Limb

Sweden
AstraZeneca
Innate Pharma

Active, not recruiting

Assessment of Efficacy and Safety of Monalizumab Plus Cetuximab Compared to Placebo Plus Cetuximab in Recurrent or Metastatic Head and Neck Cancer (INTERLINK-1)

Squamous Cell Carcinoma of the Head and Neck

United States, France, Italy, Spain, Belgium, Canada, Taiwan, Switzerland, Korea, Republic of, Japan, Poland, Russian Federation, United Kingdom, Austria, Brazil, Germany, Netherlands, Portugal, Australia, Philippines, Bulgaria, G... and more
Innate Pharma
AstraZeneca

Terminated

IPH5401 (Anti-C5aR) in Combination With Durvalumab in Patients With Advanced Solid Tumors (STELLAR-001)

Advanced Solid Tumors

United States, France
Innate Pharma
AstraZeneca

Completed

Study of Monalizumab and Cetuximab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Head and Neck Neoplasms

United States, France
Hillel Yaffe Medical Center
The Academic College at Wingate, Israel

Unknown

The Effect of a Single Bout of Balance and Coordination Exercise on Cognitive Function in Elderly People

Aging | Cognitive Decline

Israel
Hillel Yaffe Medical Center
The Zinman College for Physical Education and Sport Exercise, Wingate Institute

Unknown

Effect of Acute Exercise on Cognitive Functions

Cognitive Function in Elderly

Israel
Wingate Institute
Weizmann Institute of Science; Kaplan Medical Center; Ministry of Innovation,...

Recruiting

Identifying Periods of High Training Load Considering the Menstrual Cycle Phases in Elite and Non-elite Female Athletes

Physical Activity | Athletes | Menstrual Cycle

Israel
Innate Immunotherapeutics
Syneos Health

Completed

Safety and Efficacy Study of MIS416 to Treat Secondary Progressive Multiple Sclerosis

Secondary Progressive Multiple Sclerosis

New Zealand, Australia
Rennes University Hospital
Innate Pharma

Terminated

Immunotherapy of Hepatocellular Carcinoma With Gamma Delta T Cells (ICAR)

Hepatocellular Carcinoma

France
Canadian Cancer Trials Group
Innate Pharma

Completed

A Dose-Ranging Study of IPH2201 in Patients With Gynecologic Malignancies

Gynecologic Cancer

Canada
The Lymphoma Academic Research Organisation
Innate Pharma

Recruiting

Study of Lacutamab in Peripheral T-cell Lymphoma

Peripheral T Cell Lymphoma | Relapse/Recurrence

France, Spain, Belgium, Germany

Clinical Trials Sponsored by Wingate Institute

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kenya

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations